[5]Hyung J, Kim HD, Ryu MH, et al. GASTric Cancer HER2 Re-Assessment Study 2 (GASTHER2): HER2 Re-Assessment for Initially HER2 Negative Advanced Gastric Cancer Patients After Progression on First-Line Treatment. Cancer Res Treat. 2023 Jun 20. [6]Park SR, Park YS, Ryu MH, et al. E...
[6]Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010 Aug 28;376(97...
[2] D. Oh, W. Yeo, J. Chen, et al. Real-world treatment (Tx) patterns in patients (pts) with HER2-positive locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (HER2+ aGC/GEJC) in East ...
[9] Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-...
3.Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives. 4.Targeted therapy for gastric cancer: current status and future directions. FYI:总结生物医药更多知识点,敬请关注公众平台「佰傲谷BioValley」 部分图源网络,侵权联删发布...
摘要号：158P 研究题目 Updated Efficacy and Safety of SOX regimen combined with inetetamab as first-line treatment for HER2-positive advanced gastric cancer SOX方案联合伊尼妥单抗作为HER2阳性晚期胃癌一线治疗的有效性和安全性数据更新 研究背景 HER2阳性晚期胃癌患者的预后较差。目前，曲妥珠单抗联合化疗是该类...
2023年8月16日，浙江大学医学院附属第一医院肿瘤外科滕理送教授和浙江大学基础医学院免疫研究所周全研究员团队在Advanced Science上在线发表了题为Anti-PD-1/Her2 Bispecific Antibody IBI315 Enhances the Treatment Effect of Her2-Positive Gastric Cancer through Gasdermin B-Cleavage Induced Pyroptosis的研究论文。该...
[1] Bazell R. Her-2: The making of herceptin, a revolutionary treatment for breast cancer[M]. Random House, 2011. [2] EsTEva F J, Hortobagyi G N. Gaining ground on breast cancer[J]. Scientific American, 2008, 298(6): 58-65. ...
3. https://www.fda.gov/news-events/press-announcements/fda-approves-first-immunotherapy-initial-treatment-gastric-cancer 4.https://www.fda.gov/drugs/drug-approvals-and-databases/fda-grants-accelerated-approval-pembrolizumab-her2-positive-gastric-cancer 5.https://www.merck.com/news/fda-approves-merc...
[9]Satoh T, Xu RH, Chung HC, et al. Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN--a randomized, phase III study. J Clin Oncol. 2014 Jul 1;32(19):2039-49. ...